Selection of Nanobodies that Block the Enzymatic and Cytotoxic Activities of the Binary Clostridium Difficile Toxin CDT

UNGER M, EICHHOFF AM, SCHUMACHER L, STRYSIO M, MENZEL S, SCHWAN C, ALZOGARAY V, ZYLBERMAN V, SEMAN M, BRANDNER J, ROHDE H, ZHU K, HAAG F, MITTRÜCKER HW, GOLDBAUM FA, AKTORIES K AND KOCH-NOLTE F

Scientific Reports

Nature Publishing Group

Lugar: New York; Año: 2015 vol. 5

The spore-forming gut bacterium Clostridium difficile is the leading cause of antibiotic-associated diarrhea in hospitalized patients. The major virulence factors are two large glucosylating cytotoxins. Hypervirulent strains (e.g. ribotype 027) with higher morbidity and mortality additionally produce the binary CDT toxin (Clostridium difficile transferase) that ADP-ribosylates actin and induces microtubule-based cell protrusions. Nanobodies are robust single domain antibodies derived from camelid heavy chain antibodies.Here we report the generation of functional nanobodies against the enzymatic CDTa and the heptameric receptor binding subunit CDTb. The nanobodies were obtained from a variable-domain repertoire library isolated from llamas immunized with recombinant CDTa or CDTb. Five CDTa-specific nanobodies blocked CDTa-mediated ADP-ribosylation of actin. Three CDTa-specific and two CDTb-specific nanobodies neutralized the cytotoxicity of CDTa1b. These nanobodies hold promise as new tools for research, diagnosis and therapy of C. difficile associated disease.